BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    Creso Pharma ASX CPH granted license grow medicinal cannabis Canada Mernova facility

    Creso Pharma granted licence to grow medicinal cannabis in Canada

    Bionomics ASX BNO PTSD drug post traumatic stress disorder Phase 2 findings BNC210

    Further analysis provides greater insight into phase 2 findings of Bionomics’ PTSD drug

    Impression Healthcare ASX IHL cannabis medicine dronabinol treatment sleep apnoea

    Impression Healthcare signs deal to progress cannabis medicine ‘dronabinol’ towards treatment of sleep apnoea

    Paradigm Biopharmaceuticals ASX PAR IND applicaton mucopolysaccharidosis MPS disease

    International symposium sets scene for Paradigm Biopharmaceuticals’ MPS trial

    Orthocell ASX OCC success rate tendon injury treatment tendinopathy tendonitis

    Orthocell hails high success rate for tendon injury treatment

    Star Combo Pharma ASX S66 China Austoyou Koala Mall

    E-commerce acquisition allows Star Combo Pharma to expand its presence in China

    Althea ASX AGH medicinal cannabis United Kingdom Aphira patients

    Althea expands its medicinal cannabis offering into the UK

    PharmAust ASX PAA monepantel clinical trials humans canine dog anti-cancer tablet

    PharmAust to begin anti-cancer tablet trials in dogs this month

    Noxopharm ASX NOX interim clinical benefits treating prostate cancer Veyonda

    Noxopharm reports interim ‘clinical benefits’ in treating prostate cancer with Veyonda

    Telix Pharmaceuticals ASX TLX prostate cancer imaging technology

    Telix Pharmaceuticals partners with Mexican nuclear science firm to advance prostate imaging technology

    Creso Pharma ASX CPH medical cannabis CBD supply TerrAscend Canada

    Creso Pharma signs Canadian medicinal cannabis supply deal

    Resonance Health ASX RHT cash revenue customers FerriSmart

    Resonance posts healthy quarterly performance, boosts cash at hand figures

    Load more
    Small Caps ASX Australian stock market
    Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2019 Small Caps. All rights reserved.